David Altshuler on how human genetics informs drug discovery
Update: 2019-08-20
Description
Genetics field trip! In this episode we hopped in Jenny's car and headed to Vertex Pharmaceuticals where we spoke with Chief Scientific Officer, David Altschuler. Previously, as a core member of the Broad Institute, David's academic research focused on using human population genetics to identify therapeutic targets for complex diseases. In our conversation, David tells us about his transition into industry and how his former research strategy now informs his scientific vision at Vertex Pharmaceuticals.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
